Centre approves 30 per-cent trade margin cap on non-scheduled cancer drugs
The government has approved a 30 per-cent trade margin cap on non-scheduled anti-cancer drugs, a move expected to reduce prices…
The government has approved a 30 per-cent trade margin cap on non-scheduled anti-cancer drugs, a move expected to reduce prices…